These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 210104)

  • 1. Histological discrimination of malignancy in mucinous ovarian tumours.
    Blanco AA; Gibbs AC; Langley FA
    Histopathology; 1977 Nov; 1(6):431-43. PubMed ID: 210104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insular carcinoid of ovary associated with malignant mucinous tumors.
    Robboy SJ
    Cancer; 1984 Nov; 54(10):2273-6. PubMed ID: 6091862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum CA19.9 levels are commonly elevated in primary ovarian mucinous tumours but cannot be used to predict the histological subtype.
    Kelly PJ; Archbold P; Price JH; Cardwell C; McCluggage WG
    J Clin Pathol; 2010 Feb; 63(2):169-73. PubMed ID: 20154039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Relationship between malignant transformation of ovarian mucinous cystadenoma and intestinal epithelial metaplasia].
    Zhong CQ
    Zhonghua Bing Li Xue Za Zhi; 1989 Jun; 18(2):134-6. PubMed ID: 2555075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian epithelial tumours of borderline malignancy: pathological features and current status.
    Br J Obstet Gynaecol; 1983 Aug; 90(8):743-50. PubMed ID: 6309211
    [No Abstract]   [Full Text] [Related]  

  • 6. [Morphological prognosis factors in ovarian carcinoma].
    Stegner HE
    Geburtshilfe Frauenheilkd; 1985 Jul; 45(7):425-30. PubMed ID: 2993093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian tumours: a study of 282 cases.
    Pilli GS; Suneeta KP; Dhaded AV; Yenni VV
    J Indian Med Assoc; 2002 Jul; 100(7):420, 423-4, 447. PubMed ID: 12674165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathology of mucinous ovarian cystadenomas. I. Argyrophil and argentaffin cells and epithelial mucosubstances.
    Klemi PJ
    Acta Pathol Microbiol Scand A; 1978 Nov; 86A(6):465-70. PubMed ID: 716907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stage-specific embryonic antigen 4 expression in epithelial ovarian carcinoma.
    Ye F; Li Y; Hu Y; Zhou C; Hu Y; Chen H
    Int J Gynecol Cancer; 2010 Aug; 20(6):958-64. PubMed ID: 20683402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A clinicopathological study of 107 ovarian tumours.
    Muzaffar M; Malik IA; Ashraf S
    J Pak Med Assoc; 1987 Aug; 37(8):194-7. PubMed ID: 2824871
    [No Abstract]   [Full Text] [Related]  

  • 11. Mucinous tumors of the ovary. II. Ultrastructural features of mucinous cystadenocarcinomas.
    Fenoglio CM; Ferenczy A; Richart RM
    Am J Obstet Gynecol; 1976 Aug; 125(7):990-9. PubMed ID: 941955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneous distribution of K-ras-mutated epithelia in mucinous ovarian tumors with special reference to histopathology.
    Mandai M; Konishi I; Kuroda H; Komatsu T; Yamamoto S; Nanbu K; Matsushita K; Fukumoto M; Yamabe H; Mori T
    Hum Pathol; 1998 Jan; 29(1):34-40. PubMed ID: 9445131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroendocrine cells in cystic mucinous tumours of the ovary.
    Louwerens JK; Schaberg A; Bosman FT
    Histopathology; 1983 May; 7(3):389-98. PubMed ID: 6192070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mucinous tumors of the ovary. Anatomo-clinical aspects, histological classification, prognostic factors and histogenesis].
    Bouzourene H; Genton CY
    Arch Anat Cytol Pathol; 1997; 45(4):192-8. PubMed ID: 9406476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging in gynecological disease (11): clinical and ultrasound features of mucinous ovarian tumors.
    Moro F; Zannoni GF; Arciuolo D; Pasciuto T; Amoroso S; Mascilini F; Mainenti S; Scambia G; Testa AC
    Ultrasound Obstet Gynecol; 2017 Aug; 50(2):261-270. PubMed ID: 28782867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian epithelial tumors of borderline malignancy (carcinomas of low malignant potential).
    Hart WR
    Hum Pathol; 1977 Sep; 8(5):541-9. PubMed ID: 903145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FOXA1 is expressed in ovarian mucinous neoplasms.
    Karpathiou G; Venet M; Mobarki M; Forest F; Chauleur C; Peoc'h M
    Pathology; 2017 Apr; 49(3):271-276. PubMed ID: 28238418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CDX2 immunoreactivity in primary and metastatic ovarian mucinous tumours.
    Fraggetta F; Pelosi G; Cafici A; Scollo P; Nuciforo P; Viale G
    Virchows Arch; 2003 Dec; 443(6):782-6. PubMed ID: 14576939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common epithelial tumors of borderline malignancy (carcinomas of low malignant potential).
    Scully RE
    Bull Cancer; 1982; 69(3):228-38. PubMed ID: 6289947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Histogenetic considerations on mucinous cystomas of the ovary based on histochemical and immunohistochemical findings].
    Lapertosa G
    Pathologica; 1989; 81(1074):381-401. PubMed ID: 2696922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.